CG Oncology, Inc.

SecurityCGON / CG Oncology, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership1,507,005 shares
Latest Disclosed Value $ 101,994,129
Franklin Resources Inc reports 3.49% decrease in ownership of CGON / CG Oncology, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 1,507,005 shares of CG Oncology, Inc. (US:CGON) valued at $101,994,098 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,561,574 shares of CG Oncology, Inc.. This represents a change in shares of -3.49% during the quarter. The current value of the position is $82,011,212 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F CG ONCOLOGY COM 156944100 1,507,005 -54,569 -3.49 101,994 57.31 0.0041
2026-02-11 2025-12-31 13F CG ONCOLOGY COM 156944100 1,561,574 92,271 6.28 64,837 9.55 0.0159
2025-11-13 2025-09-30 13F CG ONCOLOGY COM 156944100 1,469,303 -17,536 -1.18 59,184 53.10 0.0148
2025-08-12 2025-06-30 13F CG ONCOLOGY COM 156944100 1,486,839 167,905 12.73 38,658 19.68 0.0102
2025-05-13 2025-03-31 13F CG ONCOLOGY COM 156944100 1,318,934 43,043 3.37 32,301 -11.73 0.0093
2025-02-12 2024-12-31 13F CG ONCOLOGY COM 156944100 1,275,891 45,698 3.71 36,593 -20.72 0.0102
2024-11-27 2024-09-30 13F/A-1 CG ONCOLOGY COM 156944100 1,230,193 100,106 8.86 46,157 29.38 0.0130
2024-11-12 2024-09-30 13F CG ONCOLOGY COM 156944100 1,230,193 100,106 46,157 0.0022
2024-08-14 2024-06-30 13F CG ONCOLOGY COM 156944100 1,130,087 281,995 33.25 35,677 -4.18 0.0110
2024-05-13 2024-03-31 13F CG ONCOLOGY COM 156944100 848,092 848,092 37,231 0.0118
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.